U.S. Markets close in 5 hrs 43 mins

New Strong Sell Stocks for March 25th

Zacks Equity Research
Investors need to pay close attention to Kala Pharmaceuticals (KALA) stock based on the movements in the options market lately.

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

21Vianet Group, Inc. VNET is a provider of carrier-neutral Internet data center services. The Zacks Consensus Estimate for its current year earnings has been revised 100% downward over the last 30 days.

Aegion Corporation AEGN is a provider of technology used in the maintenance, rehabilitation and strengthening of infrastructure. The Zacks Consensus Estimate for its current year earnings has been revised 10.2% downward over the last 30 days.

Champions Oncology, Inc. CSBR is a developer of technology solutions used in personalizing the development and use of oncology drugs. The Zacks Consensus Estimate for its current year earnings has been revised 8.3% downward over the last 30 days.

Concert Pharmaceuticals, Inc. CNCE is the owner and operator of a clinical stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 15.3% downward over the last 30 days.

Cross Country Healthcare, Inc. CCRN is a provider of healthcare staffing, recruiting and workforce solutions. The Zacks Consensus Estimate for its current year earnings has been revised 66.7% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
21Vianet Group, Inc. (VNET) : Free Stock Analysis Report
 
Aegion Corporation (AEGN) : Free Stock Analysis Report
 
Concert Pharmaceuticals, Inc. (CNCE) : Free Stock Analysis Report
 
Champions Oncology, Inc. (CSBR) : Free Stock Analysis Report
 
Cross Country Healthcare, Inc. (CCRN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research